Delivery Order SPE2DB22D1202-SPE2DB24FUMH5
Award Date 1/9/24
Potential Completion Date 1/10/24
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,377.56, is a delivery order for the supply of 4567772479 APREPITANT 40 MG CAPSULE UD 5S. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp, the prime contractor, has an extensive history of federal contract awards,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DB22D1106|SPE2DB24FEHM1) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product APREPITANT 40 MG CAPSULE UD 5S. The $2,741.69 delivery order has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of APREPITANT 40 MG CAPSULE UD 5S. The contract has a ceiling value of $29,231.36 and a performance period through September 13, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- This is a firm fixed price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,869.11 award is for the delivery of 4,564,042,367 topiramate ER 50 mg capsules. The order has an ultimate completion date of March 22, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The $8,755.27 order is for the supply of Topiramate ER 100 mg capsules, with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corporation, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies. The $32,048.10 award has a completion date of January 3, 2024. As a prime contractor, Amerisourcebergen Drug Corp has a history of delivering a range of pharmaceutical and medical products to support DLA programs. No set-aside designation was used for...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUMH5Delivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,803 APREPITANT 40 MG CAPSULE UD 5S pharmaceutical products. The $1,006.68 award has a completion date of January 10, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has an extensive history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA programs. No set-aside designation was used for this award, which will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Corporation, the parent company of the awardee, also operates under the name Cencora, Inc.
Generated 4/9/24, 5:57 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/9/24 |